⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

WRBY

Warby Parker Inc.

Healthcare · Medical Instruments & Supplies

25.91USD

+0.2400 (+0.93%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on WRBY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.09▼$0.1500
Next quarter$0.1▲$0.100
Current year$0.42▼$0.4723
Next year$0.61▼$0.6604

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.11$0.15+0.03 (+30.0%)
2026-03-31$0.11$0.11+0.00 (+3.8%)
2025-12-31$0.05$0.02-0.03 (-58.3%)
2025-09-30$0.09$0.12+0.03 (+38.1%)

Wall Street coverage

118 ratings from 20 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
UBSMaintainedNeutral$27 $28Aug 7, 2026
CitizensMaintainedMarket Outperform$30 $29Aug 7, 2026
B of A SecuritiesInitiatedBuy$33Jun 29, 2026
UBSMaintainedNeutral$25 $27May 8, 2026
BTIGMaintainedBuy$32 $34May 7, 2026
CitigroupMaintainedNeutral$18 $24Mar 17, 2026
Telsey Advisory GroupMaintainedOutperform$32Feb 20, 2026
Telsey Advisory GroupMaintainedOutperform$32Feb 10, 2026
Piper SandlerMaintainedOverweight$22 $32Dec 16, 2025
StifelMaintainedHold$19 $25Dec 12, 2025
BTIGMaintainedBuy$25 $32Dec 11, 2025
Telsey Advisory GroupMaintainedOutperform$24Nov 18, 2025
UBSMaintainedNeutral$23 $20Nov 7, 2025
Telsey Advisory GroupMaintainedOutperform$28 $24Nov 7, 2025
BTIGMaintainedBuy$28 $25Nov 6, 2025
Telsey Advisory GroupMaintainedOutperform$28Oct 31, 2025
BTIGReiteratedBuy$28Oct 28, 2025
Goldman SachsMaintainedBuy$27 $31Oct 6, 2025
UBSMaintainedNeutral$20 $23Aug 8, 2025
StifelMaintainedHold$21 $22Aug 8, 2025
Telsey Advisory GroupMaintainedOutperform$28Aug 8, 2025
Telsey Advisory GroupMaintainedOutperform$28Aug 7, 2025
BTIGMaintainedBuy$24 $28Aug 7, 2025
Telsey Advisory GroupMaintainedOutperform$22 $28Aug 1, 2025
BairdMaintainedOutperform$24 $30Jul 30, 2025

Insider transactions

132 filings from 12 insiders · 18 buy / 10 sell over 6m

Officers and directors of WRBY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Blumenthal Neil HarrisDirector; Officer, Co-Chief Executive OfficerExercise95.6k——Oct 1, 2026
Blumenthal Neil HarrisDirector; Officer, Co-Chief Executive OfficerSell100.0k$27.69$2.77MOct 1, 2026
Blumenthal Neil HarrisDirector; Officer, Co-Chief Executive OfficerExerciseClass B Common Stock95.6k——Oct 1, 2026
Raider Jeffrey JacobDirectorSell15.0k$27.70$416kOct 1, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerOther20.8k——Sep 2, 2026
GILBOA DAVID ABRAHAMChief Executive OfficerOther20.8k——Sep 2, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerExercise200.0k$25.32$5.06MAug 12, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerOther9.2k——Jul 6, 2026
GILBOA DAVID ABRAHAMChief Executive OfficerOther54.3k——Jul 6, 2026
GILBOA DAVID ABRAHAMChief Executive OfficerSell54.3k$29.84$1.62MJul 6, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerSell9.2k$29.99$276kJul 6, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerOther189.3k——Jul 1, 2026
GILBOA DAVID ABRAHAMChief Executive OfficerOther213.7k——Jul 1, 2026
RAIDER JEFFREY JACOBDirectorSell22.5k$29.72$669kJul 1, 2026
GILBOA DAVID ABRAHAMChief Executive OfficerSell242.2k$29.69$7.19MJul 1, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerSell217.7k$29.61$6.45MJul 1, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerOther36.3k——Jun 29, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerSell36.3k$30.04$1.09MJun 29, 2026
BLUMENTHAL NEIL HARRISChief Executive OfficerExercise200.0k$25.96$5.19MJun 18, 2026
BRIGGS TERESADirectorSell5.0k$25.41$130kJun 16, 2026

Analyst Notes

Sign in to write

No analyst notes on WRBY yet.

Analyst Ratings

12 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current28300Buy2.08
1 mo ago28400Buy2.14
2 mo ago28400Buy2.14
3 mo ago28400Buy2.14
Price target$31.00$25.00 – $35.00
+19.6% to target

Top voices on WRBY

Members whose judged calls on WRBY have played out most reliably.

No settled calls on WRBY yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice